Vertex Pharmaceuticals Likely To Report Q2 Profit; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Vertex Pharmaceuticals Incorporated VRTX will release earnings results for the second quarter, after the closing bell on Monday, Aug. 4.Analysts expect the Boston, Massachusetts-based company to report quarterly earnings at $4.25 per share, versus a year-ago loss of $12.83 per share. Vertex Pharmaceuticals projects to report quarterly revenue at $2.91 billion, compared to $2.65 billion a year earlier, according to data from Benzinga Pro.On July 22, Vertex announced marketing authorization in Canada for ALYF ...